Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Apply
SX-682, Carfilzomib, Daratumumab-Hyaluronidase, Dexamethasone
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step